Abstract Body

Understanding the mechanism of the establishment of HIV latency and its maintenance under antiretroviral treatment (ART) is of utmost importance. Previous studies suggest that the latent reservoir of HIV (monocytes and T cells) have elevated levels of redox buffers (e.g., glutathione [GSH] and thioredoxin [Trx]) and antioxidant enzymes (superoxide dismutase, catalase, peroxidase). Moreover, the role of GSH and Trx in maintaining viral latency is extensively studied in the HIV field. In this study, we have discovered an unexpected role of the ubiquitous gasotransmitter molecule hydrogen sulfide (H2S) in modulating HIV latency and reactivation.

Levels of H2S biogenesis machinery were examined upon HIV latency and reactivation by RT-qPCR and western blotting. The efficacy of H2S releasing donor, GYY4137, on HIV reactivation was assessed using latent cell line models and primary CD4+ T cells derived from ART-treated HIV infected patients. The mechanism of H2S gas mediated effect on HIV reactivation was studied using NanoString based analysis of selected host genes, assessing mitochondrial functions by Seahorse XF assays, and monitoring cellular redox status with redox-active fluorescent dyes

Our H2S biogenesis gene expression analysis showed that HIV reactivation is associated with the down-regulation of the key H2S producing enzyme cystathionine-?-lyase (CTH) and reduction in endogenous H2S gas levels. Consistent with this, shRNA-mediated silencing of CTH results in disruption of redox homeostasis, defective mitochondrial function, oxidation/depletion of cellular GSH, and remodels the transcriptome of latent cells to trigger HIV reactivation. Importantly, exogenous addition of H2S donor, GYY4137, in combination with ART subverted HIV rebound in latently infected primary CD4+ T cells derived from ART-treated HIV infected patients, raising the possibility of locking provirus in a deep-latent state by H2S based therapeutic interventions. Mechanistically, GYY4137 treatment subverted HIV reactivation by inducing the Keap1-Nrf2 dependent antioxidant pathway, inhibiting NF-?B activity, and recruiting the epigenetic silencer, YY1, to the HIV promoter.

In summary, this work provides mechanistic insight into H2S-mediated suppression of HIV reactivation and suggests the inclusion of an H2S donor in the current ART regimen to achieve a functional HIV cure.